Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code D60.9

Acquired pure red cell aplasia, unspecified.

Do not use this code if the type of acquired pure red cell aplasia is specified (e.g., chronic, transient, drug-induced). Use additional codes to document any underlying conditions contributing to the aplasia.

Medical necessity is established by the presence of signs and symptoms of anemia, confirmed by laboratory findings of significantly decreased red blood cell production with normal white blood cell and platelet counts.The medical necessity of specific treatments, like blood transfusions or immunosuppressants, is determined by the severity of the anemia and the underlying cause.

Diagnosis is based on history, physical exam, and symptoms. Lab tests include CBC, white blood cell analysis, reticulocyte count, and bone marrow aspiration. Imaging may involve PET and CT scans. Treatment addresses the underlying cause and may include blood transfusions, corticosteroids, or immunosuppressants.

In simple words: This code refers to a rare blood condition where the body doesn't produce enough red blood cells, leading to anemia. The exact cause isn't specified in this code.

A rare disorder characterized by a significant reduction or absence of red blood cell production in the bone marrow, while platelet and white blood cell counts remain normal.The specific type of acquired pure red cell aplasia is not specified.

Example 1: A 50-year-old patient presents with fatigue, pallor, dizziness, and shortness of breath.Blood tests reveal anemia with low red blood cell count, but normal white blood cell and platelet counts.Bone marrow aspiration confirms the diagnosis of acquired pure red cell aplasia, but the underlying cause is not immediately apparent, thus D60.9 is used., A patient with lupus develops severe anemia.After extensive testing, including a bone marrow biopsy, they are diagnosed with acquired pure red cell aplasia secondary to their autoimmune disease. However, if the type of PRCA is not specified, code D60.9 is used. Further testing is needed to identify the specific cause of the PRCA., A 30-year-old patient undergoing treatment for tuberculosis develops sudden anemia.Tests reveal acquired pure red cell aplasia, suspected to be drug-induced by the tuberculosis medication. If the drug-induced PRCA is not further specified, D60.9 should be used.

Documentation should include complete blood count (CBC) results showing anemia with reduced red blood cells, normal white blood cells and platelets, bone marrow biopsy findings consistent with PRCA, and any other relevant test results (e.g., reticulocyte count, autoimmune markers, viral studies).If an underlying cause is identified, it should be documented as well.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.